The US Food and Drug Administration’s vaccine advisors continue to be skeptical of universal boosting of all US adults with mRNA COVID-19 vaccines, but Center for Biologics Evaluation and Research Director Peter Marks indicated he may want to move in that direction anyway.
FDA unexpectedly asked the Vaccines and Related Biological Products Advisory Committee to discuss whether available data support the use of...







